These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30001348)

  • 1. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.
    Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G
    PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome.
    Nakamura A; Nomura S; Hara S; Thamamongood T; Maehara T; Nariai T; Khairullah S; Tan KS; Azuma K; Chida-Nagai A; Furutani Y; Hori T; Yamaguchi K; Kawamata T; Roder C; Akagawa H
    Sci Rep; 2024 Oct; 14(1):22720. PubMed ID: 39367156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Variant Landscape of a Large Multiethnic Population of Moyamoya Patients by Exome Sequencing.
    Shoemaker LD; Clark MJ; Patwardhan A; Chandratillake G; Garcia S; Chen R; Morgan AA; Leng N; Kirk S; Chen R; Cook DJ; Snyder M; Steinberg GK
    G3 (Bethesda); 2015 Nov; 6(1):41-9. PubMed ID: 26530418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy.
    Grangeon L; Guey S; Schwitalla JC; Bergametti F; Arnould M; Corpechot M; Hadjadj J; Riant F; Aloui C; Drunat S; Vidaud D; Tournier-Lasserve E; Kraemer M
    Stroke; 2019 Apr; 50(4):789-796. PubMed ID: 30908154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya syndrome and neurofibromatosis type 1.
    Vargiami E; Sapountzi E; Samakovitis D; Batzios S; Kyriazi M; Anastasiou A; Zafeiriou DI
    Ital J Pediatr; 2014 Jun; 40():59. PubMed ID: 24952383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
    Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
    Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
    Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
    Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient.
    Serafini NB; Serafini CB; Vinhas AS; Godinho MB
    An Bras Dermatol; 2017; 92(6):870-873. PubMed ID: 29364453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
    Wallace S; Guo DC; Regalado E; Mellor-Crummey L; Bamshad M; Nickerson DA; Dauser R; Hanchard N; Marom R; Martin E; Berka V; Sharina I; Ganesan V; Saunders D; Morris SA; Milewicz DM
    Clin Genet; 2016 Oct; 90(4):351-60. PubMed ID: 26777256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel NF1 deletion variant in a Taiwanese boy with neurofibromatosis type 1-associated Moyamoya syndrome.
    Yang YY; Yu CH; Hu CF; Sung CC; Chen SJ
    Pediatr Neonatol; 2023 Mar; 64(2):210-212. PubMed ID: 36529650
    [No Abstract]   [Full Text] [Related]  

  • 20. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy.
    Fukushima H; Takenouchi T; Kosaki K
    Am J Med Genet A; 2016 Sep; 170(9):2453-6. PubMed ID: 27375007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.